108 related articles for article (PubMed ID: 7257233)
1. Effect of transfusion regime on erythropoietin levels in refractory hypoplastic anemia.
Napier JA; Evans J
Vox Sang; 1980 Nov; 39(5):246-9. PubMed ID: 7257233
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias.
Das RE; Milne A; Rowley M; Smith EC; Cotes PM
Br J Haematol; 1992 Nov; 82(3):601-7. PubMed ID: 1486041
[TBL] [Abstract][Full Text] [Related]
3. [The difference of erythropoietin concentration in various disease].
Ming DH; Ren MY; Xie LY
Zhonghua Nei Ke Za Zhi; 1991 Jul; 30(7):421-2, 456-7. PubMed ID: 1752156
[TBL] [Abstract][Full Text] [Related]
4. [Serum erythropoietin levels and bone marrow hematopoiesis in patients with aplastic anemia].
Ogawa T
Rinsho Ketsueki; 1996 Jul; 37(7):604-9. PubMed ID: 8779780
[TBL] [Abstract][Full Text] [Related]
5. Aplastic anaemia with a trilineage response to erythropoietin therapy.
Bernell P
J Intern Med; 1996 Jan; 239(1):79-81. PubMed ID: 8551205
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in patients with myelodysplastic syndrome and myelofibrosis.
Mohr B; Herrmann R; Huhn D
Acta Haematol; 1993; 90(2):65-70. PubMed ID: 8285020
[TBL] [Abstract][Full Text] [Related]
7. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
Kurzrock R; Talpaz M; Gutterman JU
Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
[TBL] [Abstract][Full Text] [Related]
8. The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin.
Bowen D; Culligan D; Jacobs A
Br J Haematol; 1991 Mar; 77(3):419-23. PubMed ID: 2012769
[TBL] [Abstract][Full Text] [Related]
9. Treatment of transfusion-dependent anaemia of chronic renal failure with recombinant human erythropoietin. A European multicentre study in 142 patients to define dose regimen and safety profile.
Sundal E; Businger J; Kappeler A
Nephrol Dial Transplant; 1991; 6(12):955-65. PubMed ID: 1798595
[TBL] [Abstract][Full Text] [Related]
10. Haematological improvement by long-term administration of recombinant human granulocyte-colony stimulating factor and recombinant human erythropoietin in a patient with severe aplastic anaemia.
Nawata J; Toyoda Y; Nisihira H; Honda K; Kigasawa H; Nagao T
Eur J Pediatr; 1994 May; 153(5):325-7. PubMed ID: 7518392
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin in aplastic anemia.
Pavlovic-Kentera V; Milenkovic P; Ruvidic R; Jovanovic V; Biljanovic-Paunovic L
Blut; 1979 Nov; 39(5):345-50. PubMed ID: 508954
[TBL] [Abstract][Full Text] [Related]
12. High-dose recombinant human erythropoietin administered intravenously for the treatment of anaemia in myelodysplastic syndromes.
Casadevall N; Belanger C; Goy A; Varet B; Lang J; Poisson D
Acta Haematol; 1992; 87 Suppl 1():25-7. PubMed ID: 1574964
[TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin activity of blood in anemia with hypoplastic and hyperplastic bone marrow].
Essers U; Mann H
Blut; 1971 Jun; 22(6):297-305. PubMed ID: 5559035
[No Abstract] [Full Text] [Related]
14. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
Mittelman M
Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
[TBL] [Abstract][Full Text] [Related]
15. Serum erythropoietin and serum transferrin receptor levels in aplastic anaemia.
Schrezenmeier H; Noé G; Raghavachar A; Rich IN; Heimpel H; Kubanek B
Br J Haematol; 1994 Oct; 88(2):286-94. PubMed ID: 7803272
[TBL] [Abstract][Full Text] [Related]
16. [Remarkable improvement of anemia by administration of recombinant human erythropoietin in a patient with aplastic anemia].
Misago M; Mori N; Hoshuyama T; Tsukada J; Morimoto I; Oda S; Chiba S; Eto S
Rinsho Ketsueki; 1991 Aug; 32(8):912-4. PubMed ID: 1942534
[TBL] [Abstract][Full Text] [Related]
17. Iron metabolism in transgenic mice with hypoplastic anaemia due to incomplete deficiency of erythropoietin.
Raja KB; Maxwell PH; Ratcliffe PJ; Salisbury JR; Simpson RJ; Peters TJ
Br J Haematol; 1997 Feb; 96(2):248-53. PubMed ID: 9029007
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency.
Bray GL; Taylor B; O'Donnell R
J Pediatr; 1992 Apr; 120(4 Pt 1):528-32. PubMed ID: 1552389
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin therapy for aplastic anemia.
Yoshida Y
Intern Med; 1998 Mar; 37(3):235. PubMed ID: 9617855
[No Abstract] [Full Text] [Related]
20. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients.
Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T;
Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
